JAMA Clinical Reviews podcast

Diagnosis and Treatment of Systemic Lupus Erythematosus

0:00
12:48
Rewind 15 seconds
Fast Forward 15 seconds

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD.

Related Content:

More episodes from "JAMA Clinical Reviews"